about
Calibrating disease progression models using population data: a critical precursor to policy development in cancer controlA Bivariate Mixed-Effects Location-Scale Model with application to Ecological Momentary Assessment (EMA) dataA Bayesian hierarchical model for prediction of latent health states from multiple data sources with application to active surveillance of prostate cancer.A framework for the joint modeling of longitudinal diagnostic outcome data and latent infection status: application to investigating the temporal relationship between infection and disease.What if I don't treat my PSA-detected prostate cancer? Answers from three natural history models.Is prostate cancer screening cost-effective? A microsimulation model of prostate-specific antigen-based screening for British Columbia, CanadaScreening for prostate cancer using multivariate mixed-effects models.Deriving benefit of early detection from biomarker-based prognostic models.Evaluation of new technologies for cancer control based on population trends in disease incidence and mortality.Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and contextScreening for prostate cancer in the US? Reduce the harms and keep the benefit.
P2860
Q30496883-F6CF4F96-EA05-47D3-9CA2-6A86D22F41D4Q30881921-A7871553-BB6E-4D62-AF31-8206A7A953ECQ31122903-4F75B0B9-FAA7-42F6-B1CA-BD64F9499094Q34049553-267F1F53-8344-42BC-AE90-02E41F6F469BQ34963971-5B0D3C56-06B6-4D52-8BF3-0C5F3209CEC0Q35541638-BBAA5582-B408-42CB-A460-3AF36E9D7C33Q36009869-D70A96EB-CD24-4E6E-A24F-9EC1D376D444Q36623424-35E5130E-585F-44A0-A099-EDF0537CE383Q37106776-AB6D65BD-F6A4-4464-A6C5-8F5792DCCB18Q37288832-3735B925-2DC5-4F79-8C17-AFB5CD3E27AFQ51063097-A307B51D-ABAD-4723-BEE6-3349D2DF0AEF
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Modeling Disease Progression with Longitudinal Markers.
@en
Modeling Disease Progression with Longitudinal Markers.
@nl
type
label
Modeling Disease Progression with Longitudinal Markers.
@en
Modeling Disease Progression with Longitudinal Markers.
@nl
prefLabel
Modeling Disease Progression with Longitudinal Markers.
@en
Modeling Disease Progression with Longitudinal Markers.
@nl
P2093
P2860
P1476
Modeling Disease Progression with Longitudinal Markers.
@en
P2093
Christopher Morrell
Lurdes Y T Inoue
Peter Müller
Ruth Etzioni
P2860
P304
P356
10.1198/016214507000000356
P407
P577
2008-01-01T00:00:00Z